Back to top

Zymeworks price target raised to $51 from $46 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Zymeworks (ZYME) to $51 from $46 and keeps a Buy rating on the shares following updates from stra...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Jazz Pharmaceuticals PLC (JAZZ)

Johnson & Johnson (JNJ)

Zymeworks Inc. (ZYME)